GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Gross Margin %

TOWA Pharmaceutical Co (TSE:4553) Gross Margin % : 36.38% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. TOWA Pharmaceutical Co's Gross Profit for the three months ended in Dec. 2023 was 円22,168 Mil. TOWA Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円60,929 Mil. Therefore, TOWA Pharmaceutical Co's Gross Margin % for the quarter that ended in Dec. 2023 was 36.38%.

Warning Sign:

TOWA Pharmaceutical Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -4.8%.


The historical rank and industry rank for TOWA Pharmaceutical Co's Gross Margin % or its related term are showing as below:

TSE:4553' s Gross Margin % Range Over the Past 10 Years
Min: 34.66   Med: 46.01   Max: 51.75
Current: 34.66


During the past 13 years, the highest Gross Margin % of TOWA Pharmaceutical Co was 51.75%. The lowest was 34.66%. And the median was 46.01%.

TSE:4553's Gross Margin % is ranked worse than
70.42% of 987 companies
in the Drug Manufacturers industry
Industry Median: 46.24 vs TSE:4553: 34.66

TOWA Pharmaceutical Co had a gross margin of 36.38% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for TOWA Pharmaceutical Co was -4.80% per year.


TOWA Pharmaceutical Co Gross Margin % Historical Data

The historical data trend for TOWA Pharmaceutical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Gross Margin % Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.05 45.88 42.25 42.38 34.81

TOWA Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.82 31.64 36.68 34.50 36.38

Competitive Comparison of TOWA Pharmaceutical Co's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Gross Margin % falls into.



TOWA Pharmaceutical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

TOWA Pharmaceutical Co's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=72713 / 208859
=(Revenue - Cost of Goods Sold) / Revenue
=(208859 - 136146) / 208859
=34.81 %

TOWA Pharmaceutical Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=22168 / 60929
=(Revenue - Cost of Goods Sold) / Revenue
=(60929 - 38761) / 60929
=36.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


TOWA Pharmaceutical Co  (TSE:4553) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

TOWA Pharmaceutical Co had a gross margin of 36.38% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


TOWA Pharmaceutical Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TSE:4553) Business Description

Traded in Other Exchanges
N/A
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines